iRadimed Financial Statements
NASDAQ: IRMDHealthcareMedical DevicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
iRadimed revenue and earnings
In fiscal 2025, iRadimed generated $83.8 million in revenue, up 14.4% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $22.5 million (+16.9% year over year), for a net margin of 26.8% versus a median of 24.1% in the prior 5 years. Gross margin was 76.7% (down from 76.9%) and operating margin 31.2%.
Diluted earnings per share came in at $1.75, up from $1.50. Over the last 5 fiscal years, IRMD's revenue has grown at a 21.5% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
iRadimed income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 83.81M | 73.24M | 65.56M | 53.30M | 41.81M | 31.72M | 38.52M | 30.44M | 23.08M | 32.50M |
| Revenue growth (YoY) | +14.43% | +11.71% | +23.00% | +27.48% | +31.83% | -17.65% | +26.54% | +31.88% | -28.97% | +2.86% |
| Cost of Revenue | 19.49M | 16.89M | 15.40M | 12.02M | 9.76M | 8.14M | 8.82M | 7.21M | 5.57M | 6.15M |
| Gross Profit | 64.32M | 56.35M | 50.16M | 41.28M | 32.05M | 23.57M | 29.70M | 23.23M | 17.51M | 26.34M |
| Operating Expenses | 38.18M | 34.38M | 30.12M | 25.65M | 22.23M | 24.33M | 21.05M | 17.22M | 16.23M | 15.42M |
| Research & Development | 2.98M | 2.83M | 2.86M | 2.28M | 1.91M | 1.90M | 1.43M | 1.52M | 1.72M | 1.35M |
| Selling, General & Admin | 35.20M | 31.55M | 27.26M | 23.38M | 20.33M | 22.43M | 19.62M | 15.71M | 14.50M | 14.07M |
| Operating Income | 26.15M | 21.96M | 20.04M | 15.63M | 9.82M | -756.09K | 8.65M | 6.00M | 1.29M | 10.92M |
| Other Income (Expense) | 2.21M | 2.31M | 1.70M | 553.10K | 18.61K | 139.21K | 395.91K | 193.54K | 111.38K | 32.68K |
| Pretax Income | 28.36M | 24.27M | 21.74M | 16.18M | 9.84M | -616.88K | 9.04M | 6.20M | 1.40M | 10.95M |
| Income Tax | 5.88M | 5.04M | 4.55M | 3.35M | 510.82K | -1.99M | -587.64K | -106.14K | 896.62K | 3.74M |
| Net Income | 22.48M | 19.23M | 17.19M | 12.83M | 9.33M | 1.37M | 9.63M | 6.30M | 499.76K | 7.21M |
| Net Income growth (YoY) | +16.88% | +11.87% | +34.02% | +37.56% | +581.19% | -85.79% | +52.79% | +1161.29% | -93.07% | -4.19% |
| EPS (Basic) | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 | 0.85 | 0.59 | 0.05 | 0.67 |
| EPS (Diluted) | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 | 0.78 | 0.52 | 0.04 | 0.60 |
| Shares Outstanding (Basic) | 12.72M | 12.67M | 12.60M | 12.56M | 12.35M | 12.12M | 11.28M | 10.76M | 10.64M | 10.82M |
| Shares Outstanding (Diluted) | 12.85M | 12.78M | 12.72M | 12.64M | 12.59M | 12.44M | 12.28M | 12.11M | 11.72M | 11.99M |
| EBITDA | 27.31M | 22.78M | 20.80M | 16.30M | 11.22M | 582.73K | 9.89M | 7.11M | 2.59M | 11.88M |
| Gross Margin | 76.75% | 76.94% | 76.50% | 77.45% | 76.65% | 74.33% | 77.11% | 76.31% | 75.87% | 81.06% |
| Operating Margin | 31.20% | 29.99% | 30.56% | 29.32% | 23.48% | -2.38% | 22.45% | 19.72% | 5.57% | 33.60% |
| Net Margin | 26.82% | 26.26% | 26.22% | 24.07% | 22.30% | 4.32% | 25.00% | 20.71% | 2.17% | 22.20% |
This table shows 10 annual periods of iRadimed's income statement, from FY 2025 back to FY 2016, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow IRMD's reporting calendar. What is a income statement?